NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
0.500
-0.010 (-2.00%)
Jan 17, 2025, 4:00 PM EST - Market closed
NanoVibronix Employees
As of December 31, 2023, NanoVibronix had 16 total employees, including 10 full-time and 6 part-time employees. The number of employees increased by 2 or 14.29% compared to the previous year.
Employees
16
Change (1Y)
2
Growth (1Y)
14.29%
Revenue / Employee
$205,688
Profits / Employee
-$192,938
Market Cap
1.88M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
NAOV News
- 13 days ago - NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes - Business Wire
- 14 days ago - NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan - Business Wire
- 5 weeks ago - NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement - Business Wire
- 2 months ago - NanoVibronix Provides Business Update - Business Wire
- 3 months ago - NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany - Business Wire
- 4 months ago - NanoVibronix Signs Letter of Intent with Potential New Distributor - Business Wire
- 5 months ago - NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders - Business Wire
- 8 months ago - NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan - Business Wire